Sentences with phrase «cell development in»

The Center for Science in the Public Interest states that blue 1 food coloring can cause serious allergic reactions, along with inhibiting nerve cell development in children.

Among the early germ cell markers examined, VASA is a candidate gene for detecting pre-meiotic germ cell differentiation from monkey ES cells, because its expression is detected earlier in the primordial stage of germ cell development in comparison to that of PIWI family genes in vivo in mice and humans [11], [36]--[38], [49].

Besides the attempt to avoid the bioethical tug - of - war that is human stem - cell research, the scientists have a very logical reason for turning to cow eggs: In order to really study stem - cell development in a way that could lead to tangible benefits in medicine, researchers need to look at thousands and thousands of specimens, and human eggs are in short supply.

Loss of Fgfr3 leads to excess hair cell development in the mouse organ of Corti.

Martin Raff, Max Cooper, and J.J. Owen show that cells capable of producing antibodies are generated in the fetal liver of mice, demonstrating that the mouse fetal liver represents a mammalian equivalent to the avian bursa and providing an accessible in vitro system to study B cell development in the mouse.

«By further reconstituting human germ cell development in vitro, we may be able to discover the mechanisms throughout the entire developmental process from embryo to adult,» says Professor Saitou.

Now, researchers at the University of Cambridge have used fluorescent markers to track cell development in the embryo of a cartilaginous fish — a little skate in this case — and found that these thorny scales are in fact created from the same type of cells as teeth: neural crest cells.

The researchers found that cytoplasmic forms of Rbfox1 were required for germ cell development in Drosophila.

Not exact matches

They would include jobs in research and development, manufacturing and sales and would be focused on the company's next - generation cell technology.

They include ECD's low - cost cell for solar power; «rewritable» compact discs and DVDs; an instant - start, regenerative fuel cell currently in development; and a rechargeable nickel - hydride battery for powering hybrid - electric vehicles, which ECD is producing in a joint venture with Texaco.

The group already produces electric motors, which turn the wheels, as well as battery cells in - house, and is investing heavily in software development, an increasingly important part of modern cars.

But Toyota is helping spur infrastructure development for the Mirai, an effort that happily means helping along fuel - cell technology in general.

In December, SQZ partnered with global pharma firm and cancer treatment leader F. Hoffmann - La Roche in a deal that could be worth $ 500 million or more — a large undisclosed upfront payment, and additional sums when SQZ meets certain milestones — to speed up the development of its technology specifically to inject a person's immune cells with a protein to activate a «killer T» cell response to fight off canceIn December, SQZ partnered with global pharma firm and cancer treatment leader F. Hoffmann - La Roche in a deal that could be worth $ 500 million or more — a large undisclosed upfront payment, and additional sums when SQZ meets certain milestones — to speed up the development of its technology specifically to inject a person's immune cells with a protein to activate a «killer T» cell response to fight off cancein a deal that could be worth $ 500 million or more — a large undisclosed upfront payment, and additional sums when SQZ meets certain milestones — to speed up the development of its technology specifically to inject a person's immune cells with a protein to activate a «killer T» cell response to fight off cancer.

Announced a worldwide collaboration with Sangamo Therapeutics, Inc. (Sangamo) using Sangamo's zinc finger nuclease technology platform for the development of next - generation ex vivo cell therapies in oncology.

These risks and uncertainties include: Gilead's ability to achieve its anticipated full year 2018 financial results; Gilead's ability to sustain growth in revenues for its antiviral and other programs; the risk that private and public payers may be reluctant to provide, or continue to provide, coverage or reimbursement for new products, including Vosevi, Yescarta, Epclusa, Harvoni, Genvoya, Odefsey, Descovy, Biktarvy and Vemlidy ®; austerity measures in European countries that may increase the amount of discount required on Gilead's products; an increase in discounts, chargebacks and rebates due to ongoing contracts and future negotiations with commercial and government payers; a larger than anticipated shift in payer mix to more highly discounted payer segments and geographic regions and decreases in treatment duration; availability of funding for state AIDS Drug Assistance Programs (ADAPs); continued fluctuations in ADAP purchases driven by federal and state grant cycles which may not mirror patient demand and may cause fluctuations in Gilead's earnings; market share and price erosion caused by the introduction of generic versions of Viread and Truvada, an uncertain global macroeconomic environment; and potential amendments to the Affordable Care Act or other government action that could have the effect of lowering prices or reducing the number of insured patients; the possibility of unfavorable results from clinical trials involving investigational compounds; Gilead's ability to initiate clinical trials in its currently anticipated timeframes; the levels of inventory held by wholesalers and retailers which may cause fluctuations in Gilead's earnings; Kite's ability to develop and commercialize cell therapies utilizing the zinc finger nuclease technology platform and realize the benefits of the Sangamo partnership; Gilead's ability to submit new drug applications for new product candidates in the timelines currently anticipated; Gilead's ability to receive regulatory approvals in a timely manner or at all, for new and current products, including Biktarvy; Gilead's ability to successfully commercialize its products, including Biktarvy; the risk that physicians and patients may not see advantages of these products over other therapies and may therefore be reluctant to prescribe the products; Gilead's ability to successfully develop its hematology / oncology and inflammation / respiratory programs; safety and efficacy data from clinical studies may not warrant further development of Gilead's product candidates, including GS - 9620 and Yescarta in combination with Pfizer's utomilumab; Gilead's ability to pay dividends or complete its share repurchase program due to changes in its stock price, corporate or other market conditions; fluctuations in the foreign exchange rate of the U.S. dollar that may cause an unfavorable foreign currency exchange impact on Gilead's future revenues and pre-tax earnings; and other risks identified from time to time in Gilead's reports filed with the U.S. Securities and Exchange Commission (the SEC).

For those exploits that potentially apply, it is key that companies establish crisis cells to follow the development of these disclosures and be on the lookout for any patch or any attack reported in the media or social networks.

Related Content Juno Halts Development of CAR T - Cell Cancer Immunotherapy Candidate JCAR015 Two More Deaths Reported in Juno Car - T Trial

The company's CAR T - cell cancer immunotherapy furthest in development at present is JCAR017.

The research and development company is one of the largest cell phone camera module manufacturers in the world, but it also produces lenses for numerous other applications, including microscopes, drones, TVs, automobiles and more.

The United Nations Development Programme (UNDP) is planning a pilot project to test a system that allows individuals to invest in solar energy - generating cells and effectively receive rent from consumers that use the hardware.

Dumitru Vasilescu, the UNDP's lead on Moldovan private sector engagement for sustainable development goals, told ETHNews that «solar cell owners in this project will always receive SolarCoin, [which the Sun Exchange issues] in addition to their chosen Bitcoin or Fiat lease rental income.»

Cambridge, MA — March 30, 2017 — Aura Biosciences, a biotechnology company developing a new class of therapies to target and selectively destroy cancer cells using viral nanoparticle conjugates, announced today that it has enrolled and dosed the first patient in its Phase 1b clinical trial of light - activated AU - 011, an investigational, first - in - class targeted therapy in development for the treatment of ocular melanoma, a rare and life - threatening disease.

«Many investors expected a more lengthy FDA review process of the JCAR015 trial (and potentially other CAR - T programs) and feared that a higher - degree regulatory scrutiny could increase the development risk of CAR T cell,» Leerink Research said in a note co-authored by analysts Michael Schmidt, Ph.D., Jonathan Chang, Ph.D., and Varun Kumar, Ph.D. «While it may take several weeks to reopen all clinical sites of the ROCKET trial, we believe the trial shouldn't be delayed by more than ~ 3 months.»

Risk Versus Reward: The Value of Cell Therapy for Patients and Investors Source: Streetwise Reports (4/25/18) The cell therapy space, encompassing disruptive new treatment including stem cell therapy, immunotherapy and gene editing, has begun to mature, with a handful of product approvals and others in late - stage developmCell Therapy for Patients and Investors Source: Streetwise Reports (4/25/18) The cell therapy space, encompassing disruptive new treatment including stem cell therapy, immunotherapy and gene editing, has begun to mature, with a handful of product approvals and others in late - stage developmcell therapy space, encompassing disruptive new treatment including stem cell therapy, immunotherapy and gene editing, has begun to mature, with a handful of product approvals and others in late - stage developmcell therapy, immunotherapy and gene editing, has begun to mature, with a handful of product approvals and others in late - stage development.

The cell therapy space, encompassing disruptive new treatment including stem cell therapy, immunotherapy and gene editing, has begun to mature, with a handful of product approvals and others in late - stage development.

The Smart Contracts will use the blockchain technology through Eternal Trusts when the scientists working with the company make relevant developments in cloning, storing and utilizing stem cells as required by the customer.

Steven Kattman, Ph.D, is a leading expert in the development and manufacture of cell based products derived from Pluripotent Stem Cells.

In fact, it is only accelerating, thanks to trillion - dollar developments like the Internet of Things and 5G wireless networking (those cell towers need an even faster backhaul to the regular internet, which is the fiber optics come inIn fact, it is only accelerating, thanks to trillion - dollar developments like the Internet of Things and 5G wireless networking (those cell towers need an even faster backhaul to the regular internet, which is the fiber optics come inin).

«If the predicted prices for cell phone service in, say, texting are going to up, that would be sufficient to condemn the merger, and future development in other technologies are simply not going to operate as an offset to that.»

Atheists / evolutionists may want to call it evolution, just because 2 cells in their growth and development «evolved» into you.

The transitional species are oddly lacking in the fossil record.The chance development of a single cell (with DNA) is pretty difficult to explain even if you grant an evolutionist the longest period of time reasonably possible for the existance of the earth.

That physical, chemical development, from a simple egg to a complex animal, in many ways is a bigger leap than the first leap from a chemical soup to the first cell.

If you really want to know more about development and differentiation of cells and tissue... do some reading, it's pretty straight forward stuff that is well described in the literature.

Nanog is said to act at a later stage of development to keep cells in an undifferentiated state.

Nanog appears in both the morula (12 - cell stage) and in high concentration at an advanced stage of normal embryonic development, the blastocyst (150 - cell stage).

OAR produces a crippled embryo» one whose cells can divide and differentiate to a certain stage in embryonic development and no further.

The difficulties associated with obtaining nerve tissue at the correct stage of development and differentiation from aborted embryos means that foetal tissue transplantation is no longer in favour, but the creation of human embryos specifically as sources of stem cells, and the push to use «spare» embryos from IVF treatments is gatheringmomentum.

Any one who knows anything about human development knows that your body is never done making replacement cells in a living person.

The zygote's chromosomes are steadily duplicated, resulting in cell division over and over again, producing more and more cells and moving from one stage of development to the next, eventually producing a fetus.

Prior to the development of a fully functioning nervous system, and the activation of said system, a human embryo is «alive» in the same sense a tumor is «alive»: the individual cells that make it up are alive, but there is no higher - level functionality.

As specialized cells are generated during embryonic development, they are programmed to use only a limited amount of the total genetic information present in the nucleus to produce the proteins required for their particular function.

Experiments in animal cells have shown that although these genes are required to form pluripotent stem cells during development, they are not powerful enough on their own to overcome the epigenetic programming of a mature cell and convert it to a pluripotent stem cell directly.

Embryonic cells are pluripotent, having the full genetic code enabling them to become any type of cell; they differentiate into particular cells in their later development.

In both cases individual members may exercise some dominance over others, in particular by altering the patterns guiding further growth and development, but the social coordination stems from basic patterns embodied in the genetic makeup of the plant cells and in the laws and traditions of human culturIn both cases individual members may exercise some dominance over others, in particular by altering the patterns guiding further growth and development, but the social coordination stems from basic patterns embodied in the genetic makeup of the plant cells and in the laws and traditions of human culturin particular by altering the patterns guiding further growth and development, but the social coordination stems from basic patterns embodied in the genetic makeup of the plant cells and in the laws and traditions of human culturin the genetic makeup of the plant cells and in the laws and traditions of human culturin the laws and traditions of human culture.

Dennis has a PhD in genetics / developmental biology from the University of British Columbia and a special interest in studying pattern formation and cell - cell communication during tissue development using fruit flies as a model organism.

The second question has in fact two facets: (a) how does it arise in the development of the individual organism during the process of growth from the moment of fertilization of the egg; and (b) how does the egg itself come to get that way — that is to say, how can we conceive of evolution as having «designed» the cell?

Such embryo research might teach us more about cell differentiation and early embryo development, it might make possible greater success in bone marrow transplants, and it might help us to treat more successfully degenerative diseases and spinal cord injuries.

According to Mashable, Calico will specialize in new research and developments that can cause the human body's cells to wear - down at a much slower pace.

Eicosonoids from Omega - 3's are hormone - like compounds that help regulate blood pressure, blood clotting, aid in growth and development of cells, needed for vision and brain development, and maturation of nerves.

Going in chronological order, I think back to last spring when plant cells were deciding to be clusters or not and the weather was great for cluster primordia development.